SRZN Surrozen, Inc. - Common Stock
$24.92
Price · Jul 2, 2026
Fundamentals as of May 6, 2026
52W Range
$8–$35
63% of range
Analyst Rating
BUY
11 analysts
Price Target
$42
+71% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
SRZN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$24.92
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$8 – $35
SRZN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
SRZN
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
SRZN
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
SRZN
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
SRZN
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
SRZN
Peer Median
SRZN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
11 analysts
- Strong Buy 3 27.3%
- Buy 7 63.6%
- Hold 1 9.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
4 analysts · 2026-07-04
Median
$43.00
Mean
$42.50
← Below all targets
$24.92
Low
$40.00
High
$44.00
Median target
$43.00
+72.6%
Mean target
$42.50
+70.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-5.5%
Next Report
Aug 07, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-11.65 | $-1.11 | -10.5% |
| Sept. 30, 2025 | $-8.36 | $-1.16 | -7.2% |
| June 30, 2025 | $2.55 | $-1.13 | 3.7% |
| March 31, 2025 | $-7.43 | $-1.82 | -5.6% |
| Dec. 31, 2024 | $-9.10 | $-1.37 | -7.7% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SRZN | — | — | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| ELDN | $114M | -2.9 | — | — | -69.4% | — |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
| SABS | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | — |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $5M | $983.0K | |
| R&D Expense | $9M | $7M | |
| SG&A Expense | $6M | $4M | |
| Operating Expenses | $15M | $11M | |
| Operating Income | $-10M | $-10M | |
| Interest Income | $912.0K | $296.0K | |
| Other Non-op | $-41M | $38M | |
| Income Tax | $0 | $0 | |
| Net Income | $-128M | $-27M | |
| EPS (Basic) | $-11.65 | $-7.43 | |
| EPS (Diluted) | $-11.65 | $-7.43 | |
| Shares (Basic) | 10,949 | 3,628 | |
| Shares (Diluted) | 10,949 | 3,628 | |
| EBITDA | $-10M | · |
Balance Sheet 18
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $107M | · | |
| Receivables | $5M | · | |
| Prepaid Expense | $2M | · | |
| Current Assets | $114M | · | |
| PP&E (Net) | $488.0K | · | |
| Other Non-current Assets | $34.0K | · | |
| Total Assets | $121M | · | |
| Accounts Payable | $889.0K | · | |
| Accrued Liabilities | $7M | · | |
| Current Liabilities | $10M | · | |
| Capital Leases | $5M | · | |
| Total Liabilities | $399M | · | |
| Common Stock | $1.0K | · | |
| Paid-in Capital | $377M | · | |
| Retained Earnings | $-655M | · | |
| Stockholders' Equity | $-278M | · | |
| Liabilities + Equity | $121M | · | |
| Shares Outstanding | 11,490,000 | · |
Cash Flow 11
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $65.0K | $294.0K | |
| Stock-based Comp | $2M | $834.0K | |
| Deferred Tax | $0 | $0 | |
| Operating Cash Flow | $-12M | $-9M | |
| CapEx | $120.0K | $27.0K | |
| Investing Cash Flow | $-120.0K | $-27.0K | |
| Stock Issued | $0 | $76M | |
| Net Stock Activity | $0 | · | |
| Financing Cash Flow | $30M | $76M | |
| Net Change in Cash | $18M | $67M | |
| Free Cash Flow | $-13M | · |
Profitability 5
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -209.1% | · | |
| Net Margin | -2550.1% | · | |
| EBITDA Margin | -209.1% | · | |
| ROA | -108.3% | · | |
| ROE | 93.6% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 11.9 | · | |
| Quick Ratio | 11.7 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 1.4 | · |
Valuation (TTM) 9
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue TTM | $8M | · | |
| Net Income TTM | $-186M | · | |
| Market Cap | $335M | · | |
| P/E | -1.2 | · | |
| P/S | 42.1 | · | |
| P/B | -1.2 | · | |
| P / Cash Flow | -26.8 | · | |
| P / FCF | -26.5 | · | |
| Earnings Yield | -85.4% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.